Why the study?
Do paroxetine, fluoxetine, and sertraline differ in effectiveness for improving depressive symptoms and quality of life in depressed primary care patients?
Do paroxetine, fluoxetine, and sertraline differ in effectiveness for improving depressive symptoms and quality of life in depressed primary care patients?
Paroxetine, fluoxetine, and sertraline demonstrate similar effectiveness and tolerability for treating depression in primary care settings.
No takes yet. Share an insight, caveat, or question.
Supports individualized SSRI selection in primary care depression; confirms comparable mental health outcomes across these agents.
Kroenke et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: